British Columbia researchers, led by Dr. Paul Keown, aim to virtually eliminate organ rejection through advanced genetic testing, funded by Genome British Columbia, Genome Canada, and Canadian Blood Services.
Researchers in British Columbia aim to virtually eliminate organ rejection through advanced genetic testing that increases the matching accuracy between kidney donors and patients. Led by Dr. Paul Keown, the project is funded by Genome British Columbia, Genome Canada, and Canadian Blood Services. It seeks to significantly reduce the risk of a recipient's immune system rejecting a donor kidney, improving transplant outcomes.
June 04, 2024
15 Articles